Pediatric intracranial ependymoma clinical trial

Phase 2

Recruiting

• Conditions: intracranial ependymoma; ependymoma

• Registration Number: JPRN-jRCTs051180233
• Lead Sponsor: Sakamoto Hiroaki

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2019-03-30
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 40

Inclusion Criteria

Newly developed intracranial ependymoma, from 3 years old to under 20 years old (no seeding metastatic lesions)

Exclusion Criteria

Exclude those subject to any of the following conditions.
1) Active duplication cancers (simultaneous duplicated cancers and metachronous duplicated cancers with disease-free period within 5 years).
2) Heart disease with treatment is merged.
3) Pregnant or lactating women
4) When judging that the doctor in charge is inappropriate

Study & Design

• Study Type: Interventional
• Study Design: Not specified